key btk inhibitor trials for the initial treatment of cll
Published 3 years ago • 66 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
4:25
cll: state of the art in italy
-
2:02
key questions about the future of cll
-
1:58
the future role of mrd measurement in cll
-
1:09
cll treatment: discussing new data from the last 3 years
-
2:41
btk and plcg2 mutations in cll patients taking ibrutinib
-
5:26
cll: a cancer of the blood
-
2:14
targeting b-cell receptor signaling for anticancer therapy
-
13:09
niveles de conciencia
-
1:11
making clinical decisions with patients
-
3:10
ascend: acalabrutinib in r/r cll
-
3:51
significance of oral hypomethylating agents
-
1:54
workshops on cll and mrd at eric 2020
-
2:56
updates from the eric assembly
-
1:15
key themes at eha 2020
-
1:17
eric 2020 meeting
-
1:09
taking mrd from trials to the clinic
-
4:49
hematopoietic recovery post-car-t
-
4:26
transcend-cll-004: lisocabtagene maraleucel in cll
-
2:11
vjhemonc coverage in 2020!